Analyzing the top 9% yield dividend growers that raise payouts regularly and also the risks to keep in mind before investing.

Explore promising oncology stocks after Moderna/Merck melanoma data: analysts cite IOVA, NUVB, COGT, OPK, LEGN, PFE, ABT.

Energy Fuels, Inc. is the only North American company producing both uranium and separated rare earth elements (REEs), giving ...

Nvidia looks undervalued ahead of Q2 FY27 earnings as SpaceX's 10 GW data center plans could add $120–230B in revenue. Click ...

Barron’s Better Bets dividend stocks: which BBB “Dogs” offer safer yields, which look risky on cash flow, and 2027 upside ...

Nvidia Q2 earnings preview: revenue/EPS consensus, Q3 guidance stakes, Rubin/China/CPU growth drivers, $500B financing risks, ...

Realty Income reported a solid second quarter despite a slight miss on the market’s FFO estimates, with a beat on revenue.

HQH's September payout is set to reach $0.66 per share – its highest single quarterly distribution since 2015. Read why CEFs ...

Trinity Capital shows strong BDC income potential with a 12% yield, record fundings, and solid credit quality. See risks, ...

FY28 revenue outlook on data center/interconnect AI demand, but rich valuation drives a BUY-to-HOLD call. Read more here.

Explore First Trust Enhanced Equity Income Fund: 6.67% yield via covered calls, tech-heavy risks, discount to NAV, ...

Despite headwinds from the Iran War, labor demand has picked up modestly across businesses, reinforcing the view of a ...